GLP-1 and PYY for the treatment of obesity: a pilot study on the use of agonists and antagonists in diet-induced rats

GLP-1 and PYY for the treatment of obesity: a pilot study on the use of agonists and antagonists in diet-induced rats

Objective: Combination therapies with gut hormone analogs represent promising treatment strategies for obesity. This pilot study investigates the therapeutic potential of modulators of the glucagon-like peptide 1 (GLP-1) and neuropeptide Y (NPY) system using GLP-1 receptor agonists (semaglutide) and...

Full description

Bibliographic Details
Main Authors: Marie Oertel, Christian G Ziegler, Michael Kohlhaas, Alexander Nickel, Simon Kloock, Christoph Maack, Vasco Sequeira, Martin Fassnacht, Ulrich Dischinger
Format: Article
Language:English
Published: Bioscientifica 2024-02-01
Series:Endocrine Connections
Subjects:
obesity
semaglutide
glucagon-like peptide 1 (glp-1)
peptide tyrosine tyrosine 3-36 (pyy3-36)
incretin analogs
Online Access:https://ec.bioscientifica.com/view/journals/ec/13/3/EC-23-0398.xml

Internet

https://ec.bioscientifica.com/view/journals/ec/13/3/EC-23-0398.xml

Similar Items